前瞻性介入多中心研究得出的二氧化碳血管造影辅助血管内主动脉修复术最佳操作方案
该前瞻性多中心研究纳入2019至2021年五家欧洲中心接受二氧化碳血管造影辅助血管内主动脉修复术(CO2-EVAR)的65例腹主动脉瘤患者,分析各手术步骤中二氧化碳造影的图像质量和最低肾动脉(LoRA)显示情况。结论认为预置入二氧化碳造影应经股动脉导引鞘进行,近端主体释放可改善图像质量和LoRA显示,完成造影应经股动脉导引鞘进行,该方案允许以0毫升或最少碘对比剂完成手术,轻度暂时性并发症发生率低。
要点
- 预置入二氧化碳造影应经股动脉导引鞘进行,图像质量显著高于猪尾导管。
- 近端主体释放至50%和100%时LoRA显示率及图像质量显著高于猪尾导管首次造影。
- 完成二氧化碳造影应经股动脉导引鞘进行,图像质量显著高于猪尾导管。
核心结论
- 预置入二氧化碳造影应经股动脉导引鞘进行;近端主体释放产生的气体流动阻碍可改善二氧化碳图像质量和LoRA显示;CHA可单独用二氧化碳满意显示;完成二氧化碳造影应经股动脉导引鞘进行。
- 该操作方案允许以0毫升或最少碘对比剂完成CO2-EVAR,轻度暂时性并发症发生率低。
研究设计与样本
- 前瞻性介入多中心研究,2019至2021年五家欧洲中心纳入65例接受CO2-EVAR的患者。
- CO2-EVAR使用自动注射器(压力600 mmHg;体积100 cc),LoRA显示困难时注射少量碘对比剂。
- 分析四个手术步骤:预置入经猪尾导管和股动脉导引鞘的二氧化碳造影(第一步)、近端主体释放0%、50%和100%时经猪尾导管的造影(第二步)、经股动脉导引鞘注射二氧化碳显示对侧髂内动脉(CHA)(第三步)、经猪尾导管和股动脉导引鞘的完成造影(第四步)。
- 图像质量评分1=低、2=足够、3=好、4=优秀;同时评估术中及术后二氧化碳相关不良事件;使用χ2检验和Wilcoxon检验进行统计分析。
主要发现
- 65例患者中男性55/65(84.5%),中位年龄75岁(四分位距11.5岁);中位碘对比剂注射量17 cc(四分位距51 cc);19/65例(29.2%)手术使用0 cc碘对比剂;55/65例(84.2%)接受全身麻醉。
- 第一步中,经股动脉导引鞘注射二氧化碳的中位图像质量显著高于猪尾导管(猪尾导管2[四分位距3] vs 导引鞘3[四分位距3];P = .008)。
- 第二步中,近端主体释放50%时LoRA检出率高于猪尾导管首次造影(93% vs 73.2%;P = .002),100%时亦高于猪尾导管首次造影(94.1% vs 78.4%;P = .01);图像质量在50%时显著高于猪尾导管首次造影(3[四分位距3] vs 2[四分位距3];P ≤ .001),100%时亦显著高于猪尾导管首次造影(4[四分位距3] vs 2[四分位距3];P = .001)。
- 第三步中CHA检出率为93%。
- 第四步中,经导引鞘完成造影的平均图像质量显著高于猪尾导管(猪尾导管2.6 ± 1.1 vs 导引鞘3.1 ± 0.9;P ≤ .001)。
关键数值与推荐
- 预置入二氧化碳造影应经股动脉导引鞘进行。
- 近端主体释放产生的气体流动阻碍可改善二氧化碳图像质量和LoRA显示。
- CHA可单独用二氧化碳满意显示。
- 完成二氧化碳造影应经股动脉导引鞘进行。
临床怎么用
- 作者结论提出预置入和完成二氧化碳造影应经股动脉导引鞘进行,近端主体释放可改善LoRA显示和图像质量。
- 作者结论提出该操作方案允许以0 cc或最少碘对比剂完成CO2-EVAR,轻度暂时性并发症发生率低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Carbon dioxide (CO2) angiography for endovascular aortic repair (CO2-EVAR) is used to treat abdominal aortic aneurysms (AAAs), especially in patients with chronic kidney disease or allergy to iodinated contrast medium (ICM). However, some technical issues regarding the visualization of the lowest renal artery (LoRA) and the best quality image through angiographies performed from pigtail or introducer sheath are still unsolved. The aim of this study was to analyze different steps of CO2-EVAR to create an operative standardized protocol. METHODS: Patients undergoing CO2-EVAR were prospectively enrolled in five European centers from 2019 to 2021. CO2-EVAR was performed using an automated injector (pressure, 600 mmHg; volume, 100 cc); a small amount of ICM was injected in case of difficulty in LoRA visualization. LoRA visualization and image quality (1 = low, 2 = sufficient, 3 = good, 4 = excellent) were analyzed at different procedure steps: preoperative CO2 angiography from pigtail and femoral introducer sheath (first step), angiographies from pigtail at 0%, 50%, and 100% of proximal main body deployment (second step), contralateral hypogastric artery (CHA) visualization with CO2 injection from femoral introducer sheath (third step), and completion angiogram from pigtail and femoral introducer sheath (fourth step). Intraoperative and postoperative CO2-related adverse events were also evaluated. χ2 and Wilcoxon tests were used for statistical analysis. RESULTS: In the considered period, 65 patients undergoing CO2-EVAR were enrolled (55/65 [84.5%] male; median age, 75 years [interquartile range (IQR), 11.5 years]). The median ICM injected was 17 cc (IQR, 51 cc); 19 (29.2%) of 65 procedures were performed with 0 cc ICM. Fifty-five (84.2%) of 65 patients underwent general anesthesia. In the first step, median image quality was significantly higher with CO2 injected from femoral introducer (pigtail, 2 [IQR, 3] vs introducer, 3 [IQR, 3]; P = .008). In the second step, LoRA was more frequently detected at 50% (93% vs 73.2%; P = .002) and 100% (94.1% vs 78.4%; P = .01) of proximal main body deployment compared with first angiography from pigtail; similarly, image quality was significantly higher at 50% (3 [IQR, 3] vs 2 [IQR, 3]; P ≤ .001) and 100% (4 [IQR, 3] vs 2 [IQR, 3]; P = .001) of proximal main body deployment. CHA was detected in 93% cases (third step). The mean image quality was significantly higher when final angiogram (fourth step) was performed from introducer (pigtail, 2.6 ± 1.1 vs introducer, 3.1 ± 0.9; P ≤ .001). The intraoperative (7.7%) and postoperative (12.5%) adverse events (pain, vomiting, diarrhea) were all transient and clinically mild. CONCLUSIONS: Preimplant CO2 angiography should be performed from femoral introducer sheath. Gas flow impediment created by proximal main body deployment can improve image quality and LoRA visualization with CO2. CHA can be satisfactorily visualized with CO2 alone. Completion CO2 angiogram should be performed from femoral introducer sheath. This operative protocol allows performance of CO2-EVAR with 0 cc or minimal ICM, with a low rate of mild temporary complications.
引用
- Vacirca A, Faggioli G, Vaccarino R, et al. The optimal operative protocol to accomplish CO2-EVAR resulting from a prospective interventional multicenter study. J Vasc Surg. 2023. PMID: 36646335. doi:10.1016/j.jvs.2023.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。